Gsa Capital Partners LLP Rani Therapeutics Holdings, Inc. Transaction History
Gsa Capital Partners LLP
- $1.11 Billion
- Q1 2025
A detailed history of Gsa Capital Partners LLP transactions in Rani Therapeutics Holdings, Inc. stock. As of the latest transaction made, Gsa Capital Partners LLP holds 44,633 shares of RANI stock, worth $27,672. This represents 0.01% of its overall portfolio holdings.
Number of Shares
44,633Holding current value
$27,672% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding RANI
# of Institutions
44Shares Held
3.47MCall Options Held
44.3KPut Options Held
111K-
Vanguard Group Inc Valley Forge, PA800KShares$495,8000.0% of portfolio
-
Nan Fung Group Holdings LTD Central, K3494KShares$306,0220.6% of portfolio
-
Alphabet Inc. Mountain View, CA448KShares$278,0650.05% of portfolio
-
United Services Automobile Association San Antonio, TX303KShares$187,7000.01% of portfolio
-
Geode Capital Management, LLC Boston, MA196KShares$121,6540.0% of portfolio
About Rani Therapeutics Holdings, Inc.
- Ticker RANI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 24,492,000
- Market Cap $15.2M
- Description
- Rani Therapeutics Holdings, Inc. operates as a clinical stage biotherapeutics company that develops orally administered biologics. The company develops the RaniPill capsule, a platform that is intended to replace subcutaneous or IV injection of biologics with oral dosing. Its product pipeline includes RT-101, an octreotide, which has completed P...